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Abstract
 
The contribution of platelets to the process of atherosclerosis remains unclear. Here, we
show in vivo that platelets adhere to the vascular endothelium of the carotid artery in
 
ApoE
 
 
 
/
 
 
 
 mice before the development of manifest atherosclerotic lesions. Platelet–endothe-
 
lial cell interaction involved both platelet glycoprotein (GP)Ib
 
 
 
 and GPIIb-IIIa. Platelet ad-
hesion to the endothelium coincides with inflammatory gene expression and preceded ath-
erosclerotic plaque invasion by leukocytes. Prolonged blockade of platelet adhesion in
 
ApoE
 
 
 
/
 
 
 
 mice profoundly reduced leukocyte accumulation in the arterial intima and attenu-
ated atherosclerotic lesion formation in the carotid artery bifurcation, the aortic sinus, and
the coronary arteries. These findings establish the platelet as a major player in initiation of
the atherogenetic process.
Key words: platelets • endothelium • atherosclerosis • integrin • glycoprotein Ib
 
Introduction
 
Atherosclerosis is a systemic inflammatory disease charac-
terized by the accumulation of monocytes/macrophages
and lymphocytes in the intima of large arteries (1, 2). Rup-
ture or erosion of the advanced lesion initiates platelet acti-
vation and aggregation on the surface of the disrupted
atherosclerotic plaque. Thrombotic vascular occlusion is
associated with ischemic episodes, including acute coronary
syndromes or cerebral infarction. While it is widely accepted
that platelets play a significant role in thromboembolic
complications of advanced atherosclerotic lesions, their in-
volvement in the initiation of the atherosclerotic process
has received scant attention.
Several indications suggest that platelets might signifi-
cantly contribute to the inflammatory processes that pro-
mote atherosclerotic lesion formation. Platelets can ad-
 
here directly to the intact endothelial monolayer even
in the absence of endothelial disruption (3–6). During ad-
hesion platelets are activated and release proinflamma-
tory cytokines and chemoattractants (e.g., IL-1
 
 
 
, or
RANTES) and surface express CD40 ligand (CD40L) (7–
9). In vitro, interaction of platelets with endothelial cells
triggers the secretion of chemokines and the expression of
adhesion molecules and promotes the adhesion of leuko-
cytes (9–11). In this manner, the adhesion of platelets to
the endothelial surface might generate signals for recruit-
ment and extravasation of monocytes during atheroscle-
rotic plaque formation, a process of paramount impor-
tance for atherogenesis (12). However, the relevance of
platelets for initiation of atherosclerosis in vivo has not
been established.
 
The development of 
 
ApoE
 
-deficient (
 
ApoE
 
 
 
/
 
 
 
) mice
has provided an opportunity to directly assess the dynam-
ics of platelet-vessel wall interactions in the process of
atherosclerosis and to evaluate the significance of platelet
adhesion for the initiation of atherosclerotic plaque for-
mation. 
 
ApoE
 
 
 
/
 
 
 
 mice acquire widespread arterial lesions
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with a pathomorphology similar to humans that progress
from simple fatty streaks to complex fibrous plaques (13).
Using intravital microscopy we assessed platelet–endo-
thelial cell interactions in the carotid artery of 
 
ApoE
 
 
 
/
 
 
 
mice in the early and advanced stages of atherosclerosis in
vivo and evaluated the significance of platelet–endothe-
lial cell interactions for plaque formation and plaque
progression. Our results substantiate a critical role for
platelets in the initiation of atherosclerotic lesion devel-
opment.
 
Materials and Methods
 
Animals.
 
4-wk-old male 
 
ApoE
 
 
 
/
 
 
 
 (C57BL/6J-
 
ApoE
 
tm1Unc
 
)
mice (The Jackson Laboratory) consumed a 0.25% cholesterol
diet (Harlan Research diets, 0% cholate) for another 2, 4, 6, 8,
12, or 18 wk (
 
n 
 
  
 
20 per group). C57BL/6J wild-type mice
(Charles River Laboratories) served as controls (
 
n
 
   
 
20).
 
Assessment of Vascular Resistance Index by Duplex Color Sonogra-
phy.
 
The animals were anaesthetized and the common carotid
artery was visualized by duplex color sonography. Using a Acu-
son Sequoia 512 with a 15 MHz transducer (Acuson) the maxi-
mum systolic V
 
sys
 
 and the end-diastolic flow velocity V
 
dia
 
 were
determined. The resistance index of the common carotid artery
was calculated as the difference between V
 
sys
 
 and V
 
dia
 
 divided by
V
 
sys
 
.
 
Determination of Platelet and Leukocyte Adhesion.
 
Platelet and
leukocyte adhesion dynamics in the process of atherosclerosis
were monitored in vivo by use of video fluorescence micros-
copy. In brief, mice were anaesthetized by intraperitoneal injec-
tion of a solution of midazolame (5 mg/kg body weight; Ratio-
pharm), medetomidine (0.5 mg/kg body weight; Pfizer), and
fentanyl (0.05 mg/kg body weight; CuraMed Pharma GmbH).
The right common carotid artery was carefully exposed at a dis-
tance of 
 
 
 
3 mm distal and 7-mm proximal of the carotid bifur-
cation. The exposed tissue was continuously superfused with a
thermostated bicarbonate-buffered saline solution equilibrated
with 5% CO
 
2
 
 in nitrogen to maintain physiological pH. Polyeth-
ylene catheters were implanted into the right jugular vein for in-
jection of fluorescent dyes.
 
Murine Platelets Isolated from Subsets of ApoE
 
 
 
/
 
 
 
.
 
Mice from
each group or human platelets (normal or glycoprotein (GP)
 
*
 
IIb-IIIa deficient; reference 6) were labeled with CFSE (DCF).
The DCF-labeled platelet suspension was adjusted to a final
concentration of 50 
 
 
 
 10
 
6
 
 platelets per 250 
 
 
 
l and infused in-
travenously. Where indicated, fluorescent wild-type platelets
were preincubated with 50 
 
 
 
g/ml anti-GPIb
 
 
 
 (p0p/B-Fab) or
anti-GPIIb-IIIa (JON/A-F(ab)
 
2
 
 (14) for 10 min before infu-
sion. Leukocytes were stained in vivo by intravenous injection
of 100 
 
 
 
l 0.02% rhodamine 6G (Molecular Probes). Subse-
quently, the carotid artery was visualized at low (250-fold)
magnification using a Zeiss Axiotech microscope (water im-
mersion objective: 20
 
 
 
, W 20
 
 
 
/0.5; Zeiss) with a 100 W
HBO mercury lamp for epi-illumination. As illustrated in Fig.
1 A, two perpendicular axes were dropped through the origin
of the internal and the external common carotid artery. A third
line was drawn connecting the two perpendicular axes, where
they crossed the vessel wall. Platelet and leukocyte adhesion
 
were determined at high magnification (500-fold) in a 200
 
 
 
m 
 
 
 
 100 
 
 
 
m area adjacent to the third line. This implicates
that platelet recruitment was assessed exactly at the carotid bi-
furcation, which is a predilection site for the development of
atherosclerotic lesions.
All images were videotaped and evaluated off-line using a
computer-assisted image analysis program (Cap Image 7.1; Dr. H.
Zeintl, Ingenieurbüro Dr. Zeintl, Heidelberg, Germany) (refer-
ences 5 and 6). Transiently adherent platelets were defined as cells
crossing an imaginary perpendicular through the vessel at a veloc-
ity significantly lower than the centerline velocity; their numbers
are given as cells per mm
 
2
 
 endothelial surface. The number of ad-
herent cells (leukocytes or platelets) was assessed by counting the
cells that did not move or detach from the endothelial surface
within 20 s.
In a subset of experiments, we determined whether or not
platelet adhesion is restricted to lesion-prone sites within the ca-
rotid bifurcation or rather occurs throughout the entire carotid
artery. To address this issue, platelet adhesion was analyzed at the
carotid bifurcation (lesion-prone site) and in the proximal portion
of the common carotid artery, 
 
 
 
500 
 
 
 
m upstream of the carotid
bifurcation (nonlesion-prone site; see Fig. 1 A) in young (10 wk,
 
n
 
   
 
8) and old 
 
ApoE
 
 
 
/
 
 
 
 mice (
 
n
 
   
 
8, 22 wk).
 
Characterization of Intimal Inflammation and Atheroprogression.
 
After intravital videofluorescence microscopy, the animals were
killed for collection of the arterial tree. The common carotid
arteries and the descending aorta were shock-frozen for EMSA
(15). To determine monocyte recruitment into the intima of
the carotid artery and aorta, shock-frozen tissue samples were
additionally evaluated for CD14 and CD11b mRNA expression
by RT-PCR. The primer pairs were: CD11b (forward) 5
 
 
 
-
CTG GTC CAA AGC TTG GTT TT-3
 
 
 
, CD11b (reverse)
5
 
 
 
-AGC CAT CCA TTG TGA GAT CC-3
 
 
 
, CD14 (forward)
5
 
 
 
-TAC CGA CCA TGG AGC GTG TG-3
 
  
 
and CD14 (re-
verse) 5
 
 
 
-GCC GGT TAC CTC GAG ATT TT-3
 
 
 
 CD14.
The 18s ribosomal RNA was used as amplification control (for-
ward: 5
 
 
 
-CGG CTA CCA CAT CCA AGG AA-3
 
 
 
 and re-
verse: 5
 
 
 
-GCT GGA ATT ACC GCG GCT-3
 
 
 
). The remain-
ing carotid arteries were embedded in paraffin and cut into a
series of sections (5 
 
 
 
m in thickness). 20 sections downstream
of the carotid bifurcation were used for assessment of plaque
formation at the lesion-prone site. All sections were stained
with H&E. The remaining carotid arteries of each group were
opened longitudinally, mounted on slides, and stained with
Sudan III to assess plaque formation. For immunolabeling stud-
ies cryoblock (medite, Medizintechnik GmbH) embedded aor-
tae were cut into 5-
 
 
 
m sections and stained with anti–vascular
cell adhesion molecule (VCAM)-1 (rabbit polyclonal IgG), or
anti–MCP-1 (goat polyclonal IgG), purchased from Santa Cruz
Biotechnology.
 
Chronic Inhibition of Platelet Adhesion.
 
To determine the rele-
vance of platelet adhesion for atherosclerosis, 6-wk-old 
 
ApoE
 
 
 
/
 
 
 
mice were randomly assigned to receive either an irrelevant rat Ig
(50 
 
 
 
g, 
 
n 
 
  
 
4) or a rat anti–mouse GPIb
 
 
 
 (50 
 
 
 
g, mAb p0p/B,
 
n
 
  
 
 6) for another 12 wk twice a week by intraperitoneal injec-
tion. Untreated 
 
ApoE
 
 
 
/
 
 
 
 mice served as controls (
 
n
 
   
 
6). 3 d af-
ter the last mAb injection, the animals were anaesthetized, and
the vascular resistance index was determined by duplex sonogra-
phy (see above). Thereafter, leukocyte adhesion to the carotid bi-
furcation was assessed by in vivo microscopy as described above.
Subsequently, blood samples were drawn from all mice for deter-
mination of circulating rat IgG by ELISA. Finally, all mice were
killed and the carotid arteries, hearts, and ascending aortae were
 
*
 
Abbreviations used in this paper:
 
 GP, glycoprotein; VCAM, vascular cell
adhesion molecule. 
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Figure 1. Platelet adhesion to the endothelium of the common carotid artery in ApoE  /  mice in
vivo. (A) Assessment of platelet adhesion at the carotid bifurcation (lesion-prone-site, A) and within the
proximal portion of the common carotid artery. For in vivo microscopy, two imaginary perpendicular
axes were dropped through the origin of the internal and the external common carotid artery. Platelet
and leukocyte adhesion were determined at high magnification (500-fold) in a 200   100  m area ad-
jacent to a third line, connecting the perpendicular axes at their intersection with the vessel wall (lesion-
prone site, A). In a subset of experiments, platelet adhesion was also determined in the proximal portion
of the common carotid artery 500  m upstream of the carotid bifurcation (nonlesion-prone site, B).
ACC, common carotid artery; ACE, external carotid artery; ACI, internal carotid artery. (B) Platelet–
endothelial cell interactions were investigated in 6-, 8-, 10-, 12-, 16-, and 22-wk-old ApoE  /  mice
by in vivo fluorescence microscopy of the common carotid artery in situ. Wild-type animals served as
controls. The top and bottom panels summarize transient and firm platelet adhesion, respectively, of 10
experiments per group. Platelets were classified according to their interaction with the endothelial cell
lining as described previously (reference 5) and are given per mm2 of vessel surface. (C) The micropho-
tographs show representative in vivo fluorescence microscopy images at distinct time points. White
arrows indicate adherent platelets, and the black arrow indicates the area of a fatty streak. The small in-
serts demonstrate histological sections of the corresponding carotid artery under investigation (original
magnification: 200-fold). Underneath, the in vivo microscopic images representative en face carotid ar-
teries, stained with Sudan III, are given. (D) Assessment of platelet adhesion to lesion-prone (white bars) and nonlesion-prone sites (black bars). Platelet
adhesion was quantified in the proximal (nonlesion-prone) carotid artery and adjacent to the carotid bifurcation (lesion-prone) in both, young (10-wk-
old) and old (22-wk-old) ApoE /  mice (left). The photomicrograph in the middle shows a representative carotid artery, stained with Sudan III. Athero-
sclerotic plaque formation occurs preferentially at the carotid bifurcation. Representative histological sections of the carotid bifurcation and the proximal
common carotid artery are presented in the right panels (original magnification: 200-fold). 
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processed for histomorphometry according to a standardized pro-
tocol as follows.
In brief, one carotid artery per animal was excised. Carotid ar-
teries were opened longitudinally, stained with Sudan III, and
mounted on slides using glycerol gelatine. Plaque extension was
quantified as 
 
 
 
m
 
2
 
 Sudan III-stained surface area by an image anal-
ysis program (Cap Image 7.4; Dr. H. Zeintl). In addition, shock-
frozen tissue samples were evaluated for CD14 and CD11b
mRNA expression using RT-PCR, to determine monocyte re-
cruitment into the intima.
To assess cross-sectional plaque area, the remaining arterial tree
was perfusion-fixed in situ with 4% paraformaldehyde, pH 7.0).
Thereafter, the carotid arteries and hearts were excised and fur-
ther fixed with 4% paraformaldehyde for 24 h. The carotid arter-
ies were embedded in paraffin blocks and cut into 5-
 
 
 
m sections
from the distal to the proximal end. 20 sections downstream of
the carotid bifurcation were used for quantification of plaque for-
mation. The hearts and ascending aortae were embedded in par-
affin, and cross-sectioned. The sections were discarded until
reaching the junction of the heart muscle and aorta, where the
valve cusps become visible. Once this area was localized, 20 5-
 
 
 
m
sections were collected on glass slides and stained with elastica van
Giesson reagent. The area of lesions in the aortic sinus was as-
sessed by a computerized image analysis program as described
previously (16, 17). In all sections, cross-sections of the proximal
coronary arteries were identified and cross-sectional plaque area
in the proximal coronary arteries was determined using an image
analysis software.
Statistical Analysis. Comparisons between group means were
performed using Kruskal-Wallis One Way Analysis of Variance
on Ranks. Data represent mean  SEM. A value of P   0.05 was
regarded as significant.
Results and Discussion
To address the dynamic processes of platelet accumula-
tion during atherogenesis, we used in vivo fluorescence
microscopy to directly visualize and quantify platelet–vessel
wall interactions (5, 6, 18) in the common carotid artery of
ApoE /  mice in situ (Fig. 1). ApoE  /  mice reveal con-
sistent plaque formation with a pathomorphology similar to
humans (13, 19, 20). Already at the age of 6 wk, a substan-
tial increase in platelet adhesion to the carotid endothelium
was detectable in ApoE /  animals (Fig. 1 B). In contrast,
platelet–endothelial cell interactions were virtually absent
in wild-type mice. While the number of adherent platelets
constantly increased with age, the occurrence of platelet–
endothelial cell interactions strictly preceded the develop-
ment of manifest atherosclerotic lesions. In fact, the num-
ber of platelets adherent to the carotid endothelium was
significantly increased (Fig. 1, B and C) even in the com-
plete absence of early vascular alterations, as assessed ex
vivo by histomorphology (Fig. 1 C) and in vivo by color
duplex sonography (unpublished data).
Correspondingly, 10-wk-old ApoE /  mice showed
complete absence of atherosclerotic lesions in the carotid
artery, whereas both transient and firm platelet adhesion
were increased 12- and 24-fold, respectively, as compared
with wild-type mice (P   0.05). Notably, platelet recruit-
ment occurred preferentially at lesion-prone sites in young
and old ApoE / mice, since the number of adherent
platelets was significantly higher at the carotid bifurcation
compared with the proximal carotid artery (nonlesion-
prone site) in both 10- and 22-wk-old ApoE /  mice (Fig.
1 D).
Platelet adhesion to endothelial cells was followed by ac-
tivation of NF- B (unpublished data) and NF- B–regu-
lated genes, e.g., VCAM-1 (Fig. 2 A) or MCP-1 (unpub-
lished data), that play a pivotal role for chemotaxis and
endothelial transmigration of monocytes (10–12, 15, 21)
and contribute substantially to atherosclerotic lesion forma-
tion (22, 23). Importantly, we did not observe leukocyte
adhesion in ApoE /  mice before the development of ini-
tial vascular lesions as verified by in vivo microscopy (Fig. 2
B). In addition, CD14 or CD11b mRNA in the arterial
Figure 2. Platelet adhesion precedes leukocyte chemotaxis. (A) Photomicrographs show frozen sections immunostained for VCAM-1 in the time
course of atherogenesis (original magnification: 200-fold). (B) Leukocyte adhesion to the endothelium of the common carotid artery was assessed by fluo-
rescence microscopy as described previously (reference 5). The right panel shows representative in vivo fluorescence microscopy images at distinct time
points; the data are summarized in the left panel. White arrows indicate adherent leukocytes. Mean   SEM, n   10 each group. *P   0.05.891 Massberg et al.
Figure 3. Platelet membrane glycoproteins GPIb  and GPIIb-IIIa me-
diate platelet–endothelium adhesion in the common carotid artery of
ApoE /  mice. (A) Platelets were preincubated with blocking mAbs (50
 g/ml) directed against GPIb  (p0p/B-Fab) or GPIIb-IIIa (JON/A-F(ab)2
before they were administered into ApoE /  mice (10-wk-old). Platelet–
endothelial cell interactions were investigated by in vivo fluorescence mi-
croscopy (see Materials and Methods). The top panel shows representa-
tive photomicrographs, the bottom panel summarizes the data (mean and
SEM) of n   4 experiments. *P   0.05. (B) Platelets isolated from a
Glanzmann’s patient with a functional defect in the GPIIb-IIIa receptor
(reference 6) or from a healthy control individual were evaluated for
platelet–endothelium adhesion in ApoE /  mice. n   4, mean   SEM.
*P   0.05.
tree of 6-, 8-, or 10-wk-old ApoE /  mice did not differ
from wild-type animals (unpublished data). Thus, platelet
adhesion clearly preceded the recruitment of leukocytes to
the arterial wall. However, significant leukocyte recruit-
ment was encountered in mice with overt early atheroscle-
rotic lesions detectable at 12, 16, or 22 wk of age (Fig. 2
B). In line with our findings, Eriksson et al. did not observe
leukocyte–endothelium interactions in the aorta of ApoE / 
mice in the absence of atherosclerotic lesions, but demon-
strated significant leukocyte adhesion in animals with dis-
eased arteries (24, 25).
Next, we addressed the molecular determinants underly-
ing platelet adhesion in the early stage of atherogenesis be-
fore the development of manifest vascular lesions. Platelet
GPIb  and GPIIb-IIIa have been demonstrated to largely
contribute to endothelial platelet adhesion in vitro (26)
making them good candidates for inhibition. Therefore,
10-wk-old  ApoE /  mice received fluorescence-tagged
syngeneic platelets preincubated with noncytotoxic deriva-
tives of function blocking mAbs against GPIb  (p0p/B) or
GPIIb-IIIa (JON/A). Inhibition of GPIb  by p0p/B-Fab
reduced both transient and firm adhesion to the vascular
surface of the common carotid artery by 85 and 99%, re-
spectively (P   0.05) (Fig. 3 A). In contrast, inhibition of
GPIIb-IIIa by JON/A-F(ab)2 (14) had only partial effects
on transient platelet adhesion but almost completely pre-
vented firm attachment to endothelial cells in vivo (by
95%, Fig. 3 A). A similar reduction in transient and firm
adhesion to the vascular surface of the common carotid ar-
tery in ApoE /  mice was observed with human platelets892 Platelet Adhesion Contributes to Atherosclerotic Lesion Formation
isolated from a patient with Glanzmann’s thrombasthenia
that are deficient in functional GPIIb-IIIa (6) when com-
pared with normal human platelets (Fig. 3 B). Hence, we
have identified two distinct mechanisms in vivo that act in
concert to initiate recruitment of flowing platelets to the
vascular surface in the very initial stage of atherogenesis.
Similar to platelet adhesion to subendothelial matrix (27),
GPIb  is mandatory for the initial capturing process,
whereas GPIIb-IIIa is critical for firm adhesion of platelets
to the endothelium.
Next, we examined whether inhibition of platelet
adhesion mitigates atheroprogression in ApoE /  mice.
Therefore, 6-wk-old ApoE /  mice were treated with the
anti-GPIb  mAb p0p/B over a period of 12 wk (twice a
week 50  g) by intraperitoneal injection. The intact IgG
of p0p/B was chosen for this long-term treatment because
Figure 4. Reduction of atherosclerotic lesion formation after inhibition of platelet adhesion by anti-
GPIb  treatment. (A) Vascular resistance index (RI) was analyzed by color duplex sonography. Mean  
SEM of 4–6 experiments per group; *P   0.05. (B) The extension of fatty streaks ( m2) was quantified in
common carotid of ApoE /  mice by Sudan III staining in anti–GPIb -treated mice and untreated or rat
IgG-treated control animals. Data represent mean values with SEM (4–6 experiments per group) of 18-
wk-old ApoE /  mice treated 12 wk with anti-GPIb  mAb. *P   0.05. (C) Cross-sectional plaque area
was assessed on 20 serial section of the common carotid artery adjacent to the carotid bifurcation and was
evaluated for each animal as the difference between the area, delimited by the internal elastic lamina, and
the lumen area. The results were normalized to total vessel cross-sectional area to eliminate variations due
to vessel size. Data represent mean values with SEM (4–6 experiments per group) of ApoE /  mice treated
for 12 wk with anti-GPIb  mAb. *P   0.05. Representative sections (original magnification: 200-fold)
stained with elastica van Giesson reagent are presented in D. ACC, common carotid artery; ACE, external
carotid artery, ACI, internal carotid artery. (E) Role of platelet adhesion for atherosclerotic lesion forma-
tion in the aortic sinus (top panel) and the right and left main coronary arteries (bottom panel, plaque area
is presented as percentage of total cross-sectional intimal area). 18-wk-old ApoE /  mice were treated with vehicle (Control), irrelevant rat IgG, or anti-
GPIb  mAb for 12 wk. Atherosclerotic lesion formation was assessed in the aortic sinus and the proximal coronary arteries. Inhibition of platelet adhe-
sion induced a significant reduction in atherosclerotic lesion formation in the aortic sinus and the proximal coronary arteries. Aortic plaque area is pre-
sented in  m2; coronary plaque area is given as percentage of the area delimited by the internal elastic lamina (intimal area). Mean   SEM, P   0.05
versus Control. Representative histological sections of the aortic sinus and the coronary arteries stained with elastica van Giesson reagent are presented in
F and G, respectively (original magnification: 200-fold).893 Massberg et al.
Figure 4. Continued
of its higher avidity and significantly prolonged half-life in
vivo as compared with the Fab fragments of the mAb.
P0p/B inhibits binding of von Willebrand factor to
GPIb  (unpublished data) and prevents platelet adhesion
in vivo (Fig. 3 A). Furthermore, the intact IgG of p0p/B
significantly reduces the platelet count in vivo by Fc-inde-
pendent mechanisms (28). As reported earlier by Mach et
al. (29), free circulating antibody was detectable in both
groups of rat IgG-treated mice after 12 wk of treatment
(control IgG: 1.75   0.73  g/ml; anti-GPIb : 1.20  
0.90  g/ml), demonstrating that the rat Ig was not cleared
from the circulation.
Strikingly, inhibition of platelet adhesion (for 12 wk) sig-
nificantly reduced the increase in vascular resistance index
in 18-wk-old ApoE /  mice, when compared with un-
treated 18-wk-old animals (Fig. 4 A, P   0.05). Further-
more, the anti-GPIb  treatment dramatically limited ath-
erosclerotic lesion formation as compared with control
animals. Quantitative computer-assisted image analysis
showed an  90% reduction in the extent of fatty streak894 Platelet Adhesion Contributes to Atherosclerotic Lesion Formation
formation in 18-wk-old ApoE /  mice treated with anti-
GPIb  mAb for 12 wk, as assessed by Sudan III staining
(Fig. 4 B). Moreover, anti–GPIb -treated ApoE /  mice
showed substantial decreases in cross-sectional carotid
plaque area (by 81%, P   0.05) (Fig. 4 C). In contrast, in
ApoE /  mice, treated with isotype-matched control rat
IgG, atheroprogression in the carotid artery was neither ac-
celerated nor retarded, when compared with untreated
ApoE /  mice.
To exclude that the effects of chronic GPIb -inhibi-
tion on atherosclerotic lesion formation were restricted to
the carotid artery, we evaluated lesion formation in other
vascular beds including the aortic sinus and the left and
right proximal coronary artery. As demonstrated in Fig. 4,
E–G, chronic inhibition of GPIb , but not administration
of irrelevant rat IgG, significantly reduced atherosclerotic
lesion formation in both the aortic sinus (by  35%, P  
0.05) and the coronary artery (by 63%, P   0.05), com-
pared with untreated controls.
To further address the pathophysiological role of plate-
lets in the inflammatory process of atherosclerosis, we as-
sessed leukocyte recruitment to the carotid wall in 18-
wk-old ApoE-deficient mice, treated with anti-GPIb  
or irrelevant rat IgG. Leukocyte recruitment was assessed
in vivo by intravital fluorescence microscopy of the ca-
rotid bifurcation (Fig. 5 A). In addition, to determine
monocyte recruitment into the intima, shock-frozen tis-
sue samples were evaluated for CD14 and CD11b mRNA
expression using RT-PCR (Fig. 5 B). As illustrated in
Fig. 5, anti–GPIb-  but not control IgG-treated mice
showed reduced leukocyte adhesion to the vascular endo-
thelium compared with untreated control animals by
 75% (P   0.05), as determined by in vivo fluorescence
microscopy. Furthermore, intimal monocyte recruitment
was significantly attenuated as assessed by CD11b and
CD14 mRNA expression (Fig. 5 B). Together, the
present data demonstrate that inhibition of platelet adhe-
sion (to the vessel wall) at the very initial stage of athero-
genesis in ApoE /  mice attenuates intimal inflammatory
cell accumulation and results in a dramatic reduction of
early atherosclerotic lesions. These findings provide strong
evidence for a critical role of platelets and platelet–endo-
thelium adhesion in atheroma formation in response to el-
evated cholesterol, a common risk factor for cardiovascu-
lar diseases in humans.
Previous studies (3, 5, 6) and the present work show
that platelets adhere to the arterial wall in vivo in the
absence of endothelial cell denudation. GPIb  mediates
platelet adhesion under high shear rates (30) and binds
to vWF and P-selectin both of which are found on
activated endothelial cells (31, 32). Ligation of the
GPIb-IX-V complex during platelet tethering may lead to
activation of platelet integrin GPIIb-IIIa and shear-
resistant platelet deposition (33). Subsequent “outside-
in” GPIIb-IIIa signaling increases cytoplasmic Ca2 
leading to secretion of granules and local release of pre-
formed potent inflammatory mediators in areas around
adherent platelets. Previously, two cytokines, CD40L
and IL-1 , have been identified in platelets that alter
the chemotactic and adhesive properties of endothelium
by enhancing endothelial surface expression of adhesion
receptors including VCAM-1 as well as the release of
chemokines such as MCP-1 (7, 9, 10). Both VCAM-1
and MCP-1 initiate monocyte recruitment and subse-
quent transmigration across the endothelial monolayer
into the intima (12, 34) and have been shown to play a
central role in atherosclerotic lesion formation (22, 23).
Interestingly, inhibition of CD40L (29) or the lack of
CD40L expression (20) substantially reduced athero-
sclerotic lesion formation in hypercholesterolemic
mice. Here, we show for the first time that platelet ad-
hesion plays a critical role in the initiation of athero-
sclerosis. These data extend our knowledge of the early
events in the atherogenetic process and point to the im-
portance of platelets as a target for novel anti-athero-
sclerotic therapies.
Figure 5. Leukocyte recruitment to the vascular
wall of ApoE-deficient mice, treated with anti-
GPIb  mAb or irrelevant control IgG. Leukocyte
accumulation was assessed by in vivo microscopy
(A) (4–6 experiments per group) or by CD14 and
CD11b mRNA expression in the arterial wall (B).
The presence of 18s RNA served as loading control.895 Massberg et al.
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